Logo BizupsLogo Bizups
    • Investors
    • Accelerators
    • Incubators
    • Startups

      Posts

      • Home
      • Posts
      Lumira Ventures
      Reforming Interventional Cardiology
      • . Oct. 11, 2024, 9:49 p.m.

      Reforming Interventional Cardiology

      Lumira Ventures
      Lumira Ventures Celebrates Team Promotions, Emphasizes Growth and Development and Honors Female Contributions Ahead of International Women’s Day
      • . Oct. 11, 2024, 9:49 p.m.

      Lumira Ventures Celebrates Team Promotions, Emphasizes Growth and …

      Lumira Ventures
      Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating Development of Next-Generation Radioconjugates to Treat Cancer
      • . Oct. 11, 2024, 9:49 p.m.

      Fusion Pharmaceuticals to be Acquired by AstraZeneca, Accelerating …

      Lumira Ventures
      Lumira Ventures Announces Investment in Nocion Therapeutics to Revolutionize Chronic Cough Treatment
      • . Oct. 11, 2024, 9:49 p.m.

      Lumira Ventures Announces Investment in Nocion Therapeutics to …

      Lumira Ventures
      Building a Potential Cure for Type 1 Diabetes
      • . Oct. 11, 2024, 9:49 p.m.

      Building a Potential Cure for Type 1 Diabetes

      Lumira Ventures
      Charting A New Course For Chronic Cough Treatment
      • . Oct. 11, 2024, 9:49 p.m.

      Charting A New Course For Chronic Cough Treatment

      Lumira Ventures
      X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
      • . Oct. 11, 2024, 9:49 p.m.

      X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) …

      Lumira Ventures
      X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
      • . Oct. 11, 2024, 9:49 p.m.

      X4 Pharmaceuticals Announces $125 Million Capital Infusion from …

      Lumira Ventures
      AmacaThera doses First In Human Study to Evaluate, AMT-143, for Non-opioid Treatment of Post-operative Pain
      • . Oct. 11, 2024, 9:49 p.m.

      AmacaThera doses First In Human Study to Evaluate, …

      Lumira Ventures
      Transposon Receives US FDA Fast Track Designation for TPN-101 for Progressive Supranuclear Palsy
      • . Oct. 11, 2024, 9:49 p.m.

      Transposon Receives US FDA Fast Track Designation for …

        • 89
        • 90
        • 91
        • 92
        • 93
        • 94
        • 95
        • 96
        • 97

      Search Posts

      Ctegories

        Last Posts

          Media

            Logo Bizups

            Uncover the Startup Ecosystem

            • [email protected]

            Links

            • Investors
            • Accelerators
            • Incubators
            • Startups

            Links

            • Programs
            • Events
            • Mentors
            • Posts
            • Live

            Support

            • About Us
            • User Guide
            • Disclaimer
            • Privacy Policy
            • Contact Us

            Social Media

            © Bizups.info. All rights reserved.
            Login
            Sign In/Sign Up with linkedin
            Signup

            Your signup was successful. To complete the process of registering your first name, please refer to your email and confirm the email received from us.

            We found a number of people with your first name. When you find your first name in this list, select it

            This section is for the registration of real people's first name, it will be canceled in case of registration with name/organization or startup profile. After registering First name, you can add and manage your startup.Entering all requested information is mandatory